Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
OBJECTIVES Prior studies suggest that the composition of the vaginal microbiome may positively or negatively affect susceptibility to sexually transmitted infections (STI) and bacterial vaginosis (BV). Some female hormonal contraceptive methods also appear to positively or negatively influence STI transmission and BV. Therefore changes in the vaginal microbiome that are associated with different contraceptive methods may explain, in part, effects on STI transmission and BV. STUDY DESIGN We performed a retrospective study of 16S rRNA gene survey data of vaginal samples from a subset of participants from the Human Vaginal Microbiome Project at Virginia Commonwealth University. The subset included 682 women who reported using a single form of birth control that was condoms, combined oral contraceptives (COCs), depot medroxyprogesterone acetate (DMPA), or the levonorgestrel-releasing intrauterine system (LNG-IUS). RESULTS Women using COCs (adjusted odds ratio (aOR) 0.29, 95% CI [0.13, 0.64]), and DMPA (aOR 0.34, 95% CI [0.13, 0.89]), but not LNG-IUS (aOR 1.55, 95% CI [0.72, 3.35]) were less likely to be colonized by BV-associated bacteria relative to women who used condoms. Women using COCs (aOR, 1.94, 95% CI [1.25 3.02]) were more likely to be colonized by beneficial H2O2-producing Lactobacillus species compared with women using condoms, while women using DMPA (aOR 1.09, 95% CI [0.63, 1.86]) and LNG-IUS (aOR 0.74, 95% CI [0.48, 1.15]) were not. CONCLUSIONS Use of COCs is significantly associated with increased vaginal colonization by healthy lactobacilli and reduced BV-associated taxa. IMPLICATIONS COC use may positively influence gynecologic health through an increase in healthy lactobacilli and a decrease in BV-associated bacterial taxa.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192 · cited 1×
“Linear discriminant analysis effect size (LEfSe) applies a Kruskal-Wallis rank sum test for each bacterium, then uses linear discriminant analysis to estimate effect size[31].”
MethodVaginal microbiome of reproductive-age women
Ravel, J., Gajer, P., Abdo, Z., Schneider, G. M., Koenig, S. S. K., McCulle, S. L., Karlebach, S., Gorle, R., Russell, J., Tacket, C. O., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002611107 · Cited by 4,254
Molecular Identification of Bacteria Associated with Bacterial Vaginosis
Fredricks, D. N., Fiedler, T. L., & Marrazzo, J. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043802 · Cited by 1,303 · cited 1×
“4 The relationship between BV-associated bacterial taxa and contraceptive method We analyzed the prevalence of a group of bacteria that has been previously reported to have a strong association with BV, including Ureaplasma, Mycoplasma, Fusobacterium, Leptotrichia, Gardnerella, Sneathia, Prevotella, BVAB1, BVAB2, BVAB…”
MethodRomero, R., Hassan, S. S., Gajer, P., Tarca, A. L., Fadrosh, D. W., Nikita, L., Galuppi, M., Lamont, R. F., Chaemsaithong, P., Miranda, J., et al. (2014) · Microbiome · doi:10.1186/2049-2618-2-4 · Cited by 852
O'Hanlon, D. E., Moench, T. R., & Cone, R. A. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-200 · Cited by 375 · cited 1×
“There is some evidence that lactic acid is the major microbicidal component produced by vaginal lactobacilli and that H2O2 does not play an important role in killing bacteria in the anoxic conditions of the vagina[4,5].”
BackgroundNunn, K. L., Wang, Y.-Y., Harit, D., Humphrys, M. S., Ma, B., Cone, R., Ravel, J., & Lai, S. K. (2015) · mBio · doi:10.1128/mbio.01084-15 · Cited by 194 · cited 1×
“cervicovaginal mucus in such a way that trapping of HIV particles in enhanced[3].”
BackgroundMyer, L., Kuhn, L., Stein, Z. A., Wright, T. C., & Denny, L. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70298-x · Cited by 193
Breshears, L. M., Edwards, V. L., Ravel, J., & Peterson, M. L. (2015) · BMC Microbiology · doi:10.1186/s12866-015-0608-0 · Cited by 140 · cited 1×
“For example, Lactobacillus crispatus inhibits infection of HeLa cells by Chlamydia trachomatis, and inhibits growth of Neisseria gonorrhoeae in a porcine model of vaginal mucosa[1,2].”
BackgroundBradshaw, C. S., Walker, J., Fairley, C. K., Chen, M. Y., Tabrizi, S. N., Donovan, B., Kaldor, J. M., McNamee, K., Urban, E., Walker, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057688 · Cited by 95 · cited 1×
“These findings support prior studies showing a protective effect of COC use against BV [18,19,39] and expand the previous studies through the use of 16S rRNA survey data, which enabled the identification of specific”
Result
Cited by
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Racioethnic diversity in the dynamics of the vaginal microbiome during pregnancy
Serrano, M. G., Parikh, H. I., Brooks, J. P., Edwards, D. J., Arodz, T. J., Edupuganti, L., Huang, B., Girerd, P. H., Bokhari, Y. A., Bradley, S. P., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0465-8 · Cited by 300
Self-citationCervicovaginal microbiota, women's health, and reproductive outcomes
Kroon, S. J., Ravel, J., & Huston, W. M. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.06.036 · Cited by 235
The Endometrial Microbiome and Its Impact on Human Conception
Toson, B., Simon, C., & Moreno, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010485 · Cited by 131
“Strict inclusion and exclusion criteria considering hormonal treatment, antibiotic/ probiotic administration, and intrauterine devices should also be used because these interventions may influence results through changes in endometrial microbiome composition [17,27,29,30].”
BackgroundWessels, J. M., Felker, A. M., Dupont, H. A., & Kaushic, C. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.035147 · Cited by 102
“crispatus and decreased BV-associated bacteria loads (Brooks et al., 2017), supporting the findings of meta-analyses showing that hormonal contraceptives can reduce the risk of BV by up to 30% (van de Wijgert et al.”
Result
Metadata
- Authors
- Brooks, J. P., Edwards, D. J., Blithe, D. L., Fettweis, J. M., Serrano, M. G., Sheth, N. U., Strauss, J. F., Buck, G. A., & Jefferson, K. K.
- Venue
- Contraception
- Publisher
- Elsevier BV
- Published
- 2017-04
- Volume
- 95
- Issue
- 4
- Pages
- 405-413
- ISSN
- 0010-7824 (ISSN-L)
- OpenAlex
- W2558107505
- Cited by
- 128
- References
- 9
- FWCI
- 8.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome. https://app.cochat.ai/papers/10.1016/j.contraception.2016.11.006
- The paper
- Brooks, J. P., Edwards, D. J., Blithe, D. L., Fettweis, J. M., Serrano, M. G., Sheth, N. U., Strauss, J. F., Buck, G. A., & Jefferson, K. K. (2017). Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome. Contraception. https://doi.org/10.1016/j.contraception.2016.11.006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.